Biosergen held extraordinary shareholder meeting, backed 79,839,888-share rights issue at 0.5 kronor each

Reuters2026/08/06 14:38

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

At an extraordinary general meeting on Aug. 6, 2026, Biosergen adopted amendments to its articles alongside a share-capital reduction.
The meeting endorsed a reduction of share capital by SEK 4,696,464.30 without share cancellation, to reallocate to unrestricted equity; execution not confirmed.
Shareholders also adopted new share-capital limits of SEK 37.5 million to SEK 150 million, with 75,000,000 to 300,000,000 shares; implementation not confirmed.
The meeting ratified a rights issue decision for up to 79,839,888 shares at SEK 0.5 each; subscription window set for Aug. 12-26, 2026.
Shareholders approved the merger plan with Flerie via absorption, with a 31-for-1 share exchange; completion targeted for Q4 2026, pending registration.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biosergen AB published the original content used to generate this news brief on August 06, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Biosergen held extraordinary shareholder meeting, backed 79,839,888-share rights issue at 0.5 kronor each

You may also like

Crypto prices